LPL Financial’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
Other funds holding KYMR
SL
LPL Financial's KYMR Position: Q3 2026 in Review
LPL Financial increased its Kymera Therapeutics (KYMR) stake by 5.7% in Q3 2026, buying an estimated $69K and bringing the position to 11,083 shares worth $1.24M. The position accounts for ﹤0.01% of the portfolio, ranked #4310.
LPL Financial first reported a position in KYMR in Q1 2026 and has held it in 3 quarters since. 215 funds tracked by Wall St. Rank hold KYMR as of Q3 2026.
- LPL Financial held 11,083 shares of Kymera Therapeutics worth $1.24M as of Q3 2026.
- LPL Financial bought 602 Kymera Therapeutics shares in Q3 2026, an estimated $69K.
- Kymera Therapeutics made up ﹤0.01% of LPL Financial's portfolio in Q3 2026, its #4310 holding.
- LPL Financial first reported a position in Kymera Therapeutics in Q1 2026 and has held it in 3 quarters since.
- 215 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q3 2026.
Based on LPL Financial's 13F filing for Q3 2026, filed 6 Nov 2026.